Loading…
Based on limited metadata without access to the full warning letter text, AllerQuest LLC, a drug manufacturer, received an FDA warning on June 24, 2019, indicating compliance issues with federal drug regulations. The specific nature of the violations cannot be determined from the available metadata, as the subject line is not provided. The warning falls under FDA's drug product oversight authority, though the specific issuing office is not identified in this record.